Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Oncology

• Publication date

  2003-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDG238PMID 12796035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

  2003cited by this paper
• Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• An Adverse Interaction between Warfarin and 5-Fluorouracil: A Case Report and Review of the Literature

  1999cited by this paper
• Warfarin—5‐FU Interaction — A Consecutive Case Series

  1999cited by this paper
• Complications of indwelling venous access devices in cancer patients.

  1995cited by this paper
• Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

  1990cited by this paper

• Catheter Directed Thrombectomy and Other Deep Venous Interventions in Cancer Patients.

  2023cites this paper
• Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial

  2017cites this paper
• Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer

  2016cites this paper
• Venous Thromboembolism in Cancer Patients Undergoing Major Abdominal Surgery: Prevention and Management

  2012cites this paper
• The Risk Factors and Clinical Outcomes of Upper Extremity Deep Vein Thrombosis

  2012cites this paper
• Management of venous thromboembolism in patients with cancer

  2011cites this paper
• Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report

  2010cites this paper
• 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group.

  2009cites this paper
• [Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients].

  2009cites this paper
• [2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients].

  2008cites this paper
• [2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].

  2008cites this paper
• [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].

  2007cites this paper
• Thromboses sur cathéter central chez le patient cancéreux

  2007cites this paper
• High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens.

  2006cites this paper
• Warfarin-5-FU interactions.

  2006cites this paper
• Prophylaxis of central venous catheter‐related thrombosis with minidose warfarin in patients treated with high‐dose chemotherapy and peripheral‐blood stem‐cell transplantation: Retrospective analysis of 228 cancer patients

  2006cites this paper
• Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.

  2005cites this paper
• High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin

  2005cites this paper
• Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.

  2005cites this paper
• Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management.

  2005cites this paper
• Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

  2004cites this paper
• Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

  2003cites this paper